{"entity":{"type":"insider","cik":"0001629186","url":"/insider/0001629186","json_url":"/insider/0001629186.json","name":"MP 13 Ventures, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2015-08-25","last":"2024-02-20","span_basis":"filed_date"},"name_variants":[{"name":"MP 13 Ventures, LLC","source":"filing","n_filings":10,"first_seen":"2015-08-25","last_seen":"2024-02-20"}],"transactions":[{"id":2175646,"accession":"0000950170-24-017225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-017225","line_url":"/filing/0000950170-24-017225#line-1","is_derivative":false,"issuer_cik":"0001189020","issuer_name":"Heliogen, Inc.","issuer_ticker":"HLGN","issuer_name_source":null,"issuer_url":"/issuer/0001189020","owner_cik":null,"owner_name":"Cambridge Equities, LP; MP 13 Ventures, LLC; Nant Capital, LLC; SOON-SHIONG PATRICK","owner_display_name":"Cambridge Equities, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":442298.0,"shares_display":"442,298","price_per_share":1.5195,"price_display":"1.52","price_state":"stated","total_value":672071.811,"total_display":"672,071.81","total_whole":"672,072","shares_owned_after":442298.0,"shares_owned_after_display":"442,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":5427781,"accession":"0000899243-21-015976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-015976","line_url":"/filing/0000899243-21-015976#line-1","is_derivative":false,"issuer_cik":"0001189020","issuer_name":"NantHealth, Inc.","issuer_ticker":"NH","issuer_name_source":null,"issuer_url":"/issuer/0001189020","owner_cik":null,"owner_name":"SOON-SHIONG PATRICK; Cambridge Equities, LP; MP 13 Ventures, LLC; CALIFORNIA CAPITAL EQUITY, LLC; NantWorks, LLC","owner_display_name":"SOON-SHIONG PATRICK","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1689189.0,"shares_display":"1,689,189","price_per_share":2.96,"price_display":"2.96","price_state":"stated","total_value":4999999.44,"total_display":"4,999,999.44","total_whole":"4,999,999","shares_owned_after":1689189.0,"shares_owned_after_display":"1,689,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-15","scope":"insider"},{"id":3089929,"accession":"0001209191-20-039238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-039238","line_url":"/filing/0001209191-20-039238#line-1","is_derivative":false,"issuer_cik":"0001189020","issuer_name":"NantKwest, Inc.","issuer_ticker":"NK","issuer_name_source":null,"issuer_url":"/issuer/0001189020","owner_cik":null,"owner_name":"Cambridge Equities, LP; SOON-SHIONG PATRICK; MP 13 Ventures, LLC","owner_display_name":"Cambridge Equities, LP","owner_url":null,"role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3710000.0,"shares_display":"3,710,000","price_per_share":12.12,"price_display":"12.12","price_state":"stated","total_value":44965200.0,"total_display":"44,965,200.00","total_whole":"44,965,200","shares_owned_after":23750750.0,"shares_owned_after_display":"23,750,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-06-29","scope":"insider"},{"id":3175150,"accession":"0001209191-16-132328","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-132328","line_url":"/filing/0001209191-16-132328#line-3","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"MP 13 Ventures, LLC; SOON-SHIONG PATRICK; Chan Soon-Shiong Family Foundation; Cambridge Equities, LP","owner_display_name":"MP 13 Ventures, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7878098.0,"shares_display":"7,878,098","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-07","filed_date":"2016-07-11","scope":"insider"},{"id":3256346,"accession":"0001209191-16-130577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-130577","line_url":"/filing/0001209191-16-130577#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"Chan Soon-Shiong Family Foundation; SOON-SHIONG PATRICK; MP 13 Ventures, LLC; Cambridge Equities, LP","owner_display_name":"Chan Soon-Shiong Family Foundation","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":5.819,"price_display":"5.82","price_state":"stated","total_value":19784.6,"total_display":"19,784.60","total_whole":"19,785","shares_owned_after":7157924.0,"shares_owned_after_display":"7,157,924","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-29","filed_date":"2016-07-01","scope":"insider"},{"id":2959852,"accession":"0001209191-16-129634","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-129634","line_url":"/filing/0001209191-16-129634#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"MP 13 Ventures, LLC; Cambridge Equities, LP; Chan Soon-Shiong Family Foundation; SOON-SHIONG PATRICK","owner_display_name":"MP 13 Ventures, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6901.0,"shares_display":"6,901","price_per_share":5.854,"price_display":"5.85","price_state":"stated","total_value":40398.454,"total_display":"40,398.45","total_whole":"40,398","shares_owned_after":7161324.0,"shares_owned_after_display":"7,161,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-23","filed_date":"2016-06-24","scope":"insider"},{"id":2249838,"accession":"0001209191-16-128650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-128650","line_url":"/filing/0001209191-16-128650#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"Chan Soon-Shiong Family Foundation; SOON-SHIONG PATRICK; Cambridge Equities, LP; MP 13 Ventures, LLC","owner_display_name":"Chan Soon-Shiong Family Foundation","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19836.0,"shares_display":"19,836","price_per_share":5.872,"price_display":"5.87","price_state":"stated","total_value":116476.992,"total_display":"116,476.99","total_whole":"116,477","shares_owned_after":7168225.0,"shares_owned_after_display":"7,168,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-15","filed_date":"2016-06-17","scope":"insider"},{"id":2550447,"accession":"0001209191-16-128024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-128024","line_url":"/filing/0001209191-16-128024#line-2","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"SOON-SHIONG PATRICK; MP 13 Ventures, LLC; Cambridge Equities, LP; Chan Soon-Shiong Family Foundation","owner_display_name":"SOON-SHIONG PATRICK","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15972.0,"shares_display":"15,972","price_per_share":6.114,"price_display":"6.11","price_state":"stated","total_value":97652.808,"total_display":"97,652.81","total_whole":"97,653","shares_owned_after":720174.0,"shares_owned_after_display":"720,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-14","filed_date":"2016-06-15","scope":"insider"},{"id":2550442,"accession":"0001209191-16-128024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-128024","line_url":"/filing/0001209191-16-128024#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"SOON-SHIONG PATRICK; MP 13 Ventures, LLC; Cambridge Equities, LP; Chan Soon-Shiong Family Foundation","owner_display_name":"SOON-SHIONG PATRICK","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37792.0,"shares_display":"37,792","price_per_share":6.145,"price_display":"6.14","price_state":"stated","total_value":232231.84,"total_display":"232,231.84","total_whole":"232,232","shares_owned_after":736146.0,"shares_owned_after_display":"736,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-15","scope":"insider"},{"id":2368670,"accession":"0001209191-16-107197","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-107197","line_url":"/filing/0001209191-16-107197#line-2","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"Chan Soon-Shiong Family Foundation; MP 13 Ventures, LLC; Cambridge Equities, LP; SOON-SHIONG PATRICK","owner_display_name":"Chan Soon-Shiong Family Foundation","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85300.0,"shares_display":"85,300","price_per_share":6.17,"price_display":"6.17","price_state":"stated","total_value":526301.0,"total_display":"526,301.00","total_whole":"526,301","shares_owned_after":773938.0,"shares_owned_after_display":"773,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-08","scope":"insider"},{"id":2368663,"accession":"0001209191-16-107197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-107197","line_url":"/filing/0001209191-16-107197#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":null,"owner_name":"Chan Soon-Shiong Family Foundation; MP 13 Ventures, LLC; Cambridge Equities, LP; SOON-SHIONG PATRICK","owner_display_name":"Chan Soon-Shiong Family Foundation","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14700.0,"shares_display":"14,700","price_per_share":6.34,"price_display":"6.34","price_state":"stated","total_value":93198.0,"total_display":"93,198.00","total_whole":"93,198","shares_owned_after":859238.0,"shares_owned_after_display":"859,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-04","filed_date":"2016-03-08","scope":"insider"},{"id":8886470,"accession":"0001209191-15-067793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-067793","line_url":"/filing/0001209191-15-067793#line-1","is_derivative":false,"issuer_cik":"0001189020","issuer_name":"NantKwest, Inc.","issuer_ticker":"NK","issuer_name_source":null,"issuer_url":"/issuer/0001189020","owner_cik":null,"owner_name":"MP 13 Ventures, LLC; Cambridge Equities, LP; SOON-SHIONG PATRICK","owner_display_name":"MP 13 Ventures, LLC","owner_url":null,"role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":10350000.0,"total_display":"10,350,000.00","total_whole":"10,350,000","shares_owned_after":41016557.0,"shares_owned_after_display":"41,016,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-21","filed_date":"2015-08-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840292","name":"Heliogen, Inc.","url":"/issuer/0001840292","role":"Ten percent owner","n_filings":1,"first_seen":"2024-02-20","last_seen":"2024-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001566469","name":"NantHealth, Inc.","url":"/issuer/0001566469","role":"Ten percent owner","n_filings":1,"first_seen":"2021-04-15","last_seen":"2021-04-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001326110","name":"NantKwest, Inc.","url":"/issuer/0001326110","role":"Ten percent owner","n_filings":2,"first_seen":"2015-08-25","last_seen":"2020-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000850261","name":"Sorrento Therapeutics, Inc.","url":"/issuer/0000850261","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2016-03-08","last_seen":"2016-07-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001629186","retrieved_at":"2026-08-24T13:42:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}